Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | MLAB |
---|---|---|
10:12 ET | 291 | 199.45 |
10:14 ET | 100 | 200.3 |
10:15 ET | 200 | 200.7 |
10:17 ET | 300 | 200.97 |
10:19 ET | 1100 | 200.1 |
10:26 ET | 320 | 200.33 |
10:28 ET | 308 | 200.4 |
10:30 ET | 300 | 199.65 |
10:33 ET | 200 | 200.33 |
10:35 ET | 100 | 200.35 |
10:37 ET | 510 | 199.49 |
10:46 ET | 670 | 199.7 |
11:15 ET | 100 | 202.45 |
11:27 ET | 100 | 203.58 |
11:36 ET | 109 | 203.6 |
11:45 ET | 100 | 204.42 |
11:47 ET | 509 | 204.5 |
12:27 ET | 100 | 206.13 |
12:54 ET | 100 | 206.7 |
01:12 ET | 100 | 205.49 |
01:44 ET | 100 | 205.55 |
02:00 ET | 100 | 205.89 |
02:36 ET | 100 | 206.25 |
02:47 ET | 200 | 205.79 |
02:51 ET | 100 | 205.24 |
03:07 ET | 100 | 203.63 |
03:12 ET | 100 | 202.83 |
03:14 ET | 100 | 202.75 |
03:16 ET | 100 | 203.245 |
03:20 ET | 200 | 203.11 |
03:34 ET | 100 | 203.73 |
03:39 ET | 200 | 204.58 |
03:41 ET | 200 | 203.631 |
03:45 ET | 300 | 204.15 |
03:52 ET | 100 | 203.55 |
03:54 ET | 100 | 203.26 |
03:56 ET | 100 | 203.21 |
03:57 ET | 100 | 203.49 |
03:59 ET | 100 | 203.94 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Mesa Laboratories Inc | 1.1B | 601.5x | -34.50% |
Omega Flex Inc | 1.1B | 42.8x | +12.74% |
Energy Recovery Inc | 1.1B | 74.1x | +28.26% |
Distribution Solutions Group Inc | 998.0M | 32.5x | --- |
Fathom Digital Manufacturing Corp | 526.1M | 5.9x | --- |
NL Industries Inc | 481.7M | 8.5x | +27.23% |
Mesa Laboratories, Inc. is a multinational manufacturer, developer, and seller of quality control products and services. The Company's segments include Sterilization and Disinfection Control, Biopharmaceutical Development, Calibration Solutions, and Clinical Genomics. Its Sterilization and Disinfection Control segment manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization processes. Its Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. Its Calibration Solutions segment develops, manufactures, and sells quality control and calibration products used to measure or calibrate temperature, pressure, pH, humidity, and other such parameters. Its Clinical Genomics segment develops, manufactures, and sells throughput genetic analysis tools used by labs to perform clinical genomic testing in several therapeutic areas.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.1B |
---|---|
Revenue (TTM) | $184.3M |
Shares Outstanding | 5.3M |
Dividend Yield | 0.31% |
Annual Dividend Rate | 0.6400 USD |
Ex-Dividend Date | 05-27-22 |
Pay Date | 06-15-22 |
Beta | 0.53 |
EPS | $0.34 |
Book Value | $74.79 |
P/E Ratio | 601.5x |
Price/Sales (TTM) | 5.8 |
Price/Cash Flow (TTM) | 39.9x |
Operating Margin | 2.55% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.